לבטיראצטם טבע ® 1000 מ"ג

Land: Israel

Språk: hebreiska

Källa: Ministry of Health

Aktiva substanser:

LEVETIRACETAM 1000 MG

Tillgänglig från:

TEVA PHARMACEUTICAL INDUST.LTD

ATC-kod:

N03AX14

Läkemedelsform:

TABLETS

Administreringssätt:

PER OS

Tillverkad av:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Terapeutisk grupp:

LEVETIRACETAM

Terapeutiska indikationer:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Tillstånd datum:

2009-09-01